跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Galantamine Hydrobromide Extended Release Capsules 16mg Bottle - TGA Drug Approval Details
Approvals
/
TGA
/
Galantamine Hydrobromide Extended Release Capsules 16mg Bottle
Approved
STANDARD
Galantamine Hydrobromide Extended Release Capsules 16mg Bottle
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
47d6cbaa81c8bfb3
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
47d6cbaa81c8bfb3
Product Name
Galantamine Hydrobromide Extended Release Capsules 16mg Bottle
Artg Id
201906
Artg Name
Galantamine Hydrobromide Extended Release Capsules 16mg Bottle
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2012-10-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
47d6cbaa81c8bfb3
Type
Standard
Back to TGA Approvals
